A device for cleaning umbilical cord blood hematopoietic stem cells after thawing and a thawing, cleaning and preservation method based thereon

By designing a post-thawing cleaning device for cord blood hematopoietic stem cells and a thawing cleaning and preservation method, the thawing diluent and cell preservation solution are used to clean and preserve cord blood, the dangers and complex operation problems in the low-temperature transportation and thawing of liquid nitrogen are solved. , realizes the safety and effectiveness of long-distance transportation of umbilical cord blood and clinical application.

CN111701097BActive Publication Date: 2024-11-15BEIJING JIACHENHONG BIOLOGICAL TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202010674174.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2020-07-14
Publication Date
2024-11-15
Estimated Expiration
2040-07-14

AI Technical Summary

Technical Problem

The prior art has problems such as risky, complex operation, risk of freezing bag damage and difficult to maintain cell activity after thawing during the low temperature transportation and thawing of liquid nitrogen of umbilical cord blood, resulting in limited clinical application.

Method used

A post-thawing cleaning device for umbilical cord blood hematopoietic stem cells and corresponding thawing cleaning and preservation methods are designed. The thawing diluent and cell preservation solution are used to clean and preserve umbilical cord blood, and the effective umbilical cord blood is achieved through the Y-shaped pipe and clamp structure. Clean and store to ensure cell integrity and activity.

Benefits of technology

The thawed umbilical cord blood is stored for at least 72 hours in a 4°C environment, which significantly reduces the occurrence of adverse infusion reactions, simplifies transportation and operation procedures, and ensures the feasibility of long-distance transportation and the safety of clinical applications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN111701097B_ABST
    Figure CN111701097B_ABST
Patent Text Reader

Abstract

The present invention provides a cord blood hematopoietic stem cell post-thawing cleaning device and a thawing cleaning and preservation method based thereon, the device comprises an infusion bag and a transfer bag, a sample adding port and an infusion socket are arranged on the upper part of the infusion bag, a Y-type pipeline is connected through the sample adding port, the other two ends of the Y-type pipeline are connected to the puncture head and the Luer interface, the first pipeline clamp, the third pipeline clamp and the fourth pipeline clamp are arranged on the three sections of the Y-type pipeline respectively, the infusion bag and the transfer bag are connected by a catheter, and the second pipeline clamp is arranged on the catheter; the thawing cleaning and preservation method comprises the steps of freezing and resuming the umbilical cord blood, adding a thawing diluent, centrifuging and adding a cell preservation solution. Using the device of the present invention to clean the thawed umbilical cord blood and perform subsequent clinical infusion is not only convenient for daily operation, but also the thawed umbilical cord blood hematopoietic stem cells can be placed at 4°C for at least 72 hours, which can meet the needs of long-distance transportation.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of medicine and biology, and particularly relates to a device for cleaning umbilical cord blood hematopoietic stem cells after thawing and a thawing, cleaning and preservation method based on the device. Background Art

[0002] Umbilical cord blood hematopoietic stem cells can be used for hematopoietic stem cell transplantation and the treatment of many diseases such as the blood system and immune system, and have important clinical application value. Umbilical cord blood hematopoietic stem cells are mostly stored in the form of liquid nitrogen in the umbilical cord blood bank, and need to be thawed and resuscitated in clinical applications. If the thawed and resuscitated umbilical cord blood is not processed, it needs to be infused within 30 minutes, otherwise the activity is difficult to guarantee. By using the dilution method, the thawed umbilical cord blood can be placed at 4°C for 4 hours. If the cryoprotectant is removed by centrifugation, the thawed umbilical cord blood can be placed at 4°C for 24 hours. Because the centrifugal removal of cryoprotectant method will lead to a large loss of umbilical cord blood cells, and the dilution method has a limited extension of the storage time, the current clinical application of umbilical cord blood in China adopts the method of immediate infusion after thawing. This requires that the umbilical cord blood be transported to clinical medical institutions in advance by liquid nitrogen low-temperature transportation, and then thawed and resuscitated in the ward.

[0003] The prior art has the following problems:

[0004] (1) Liquid nitrogen is a hazardous chemical. There are cases where it is not permitted to use liquid nitrogen tanks for air or rail transportation.

[0005] (2) The operation of cryogenic transportation of umbilical cord blood by liquid nitrogen is relatively complex and has high requirements in all aspects. First, the portable liquid nitrogen tank used for transportation needs to be verified for reliability before each transportation; second, during the transportation process, two staff members are generally required to escort and monitor the temperature throughout the process; finally, the thawing and resuscitation of umbilical cord blood needs to be completed by full-time staff of the umbilical cord blood bank to deal with various emergencies that may arise.

[0006] (3) Even if all preparations are done and the operation is done carefully, it is still impossible to completely avoid the freezing bag from breaking during thawing. Once this happens, the hematopoietic stem cell transplant patient will be in a very dangerous situation. Because when the umbilical cord blood is thawed, the patient usually undergoes pre-transplantation pretreatment, and the hematopoietic and immune systems are almost completely cleared and suppressed. If the umbilical cord blood is not transfused in time, serious complications such as infection may occur at any time.

[0007] (4) Because thawed umbilical cord blood contains free hemoglobin and cryoprotectants, direct transfusion may cause adverse reactions in patients, and preventive treatment before transfusion and symptomatic treatment after transfusion are required.

[0008] Therefore, how to maximize the storage time of umbilical cord blood after thawing is an urgent problem that needs to be solved. Summary of the invention

[0009] In view of the problems existing in the prior art, the purpose of the present invention is to provide a device for cleaning umbilical cord blood hematopoietic stem cells after thawing and a thawing, cleaning and preservation method based thereon. The device is used to clean the thawed umbilical cord blood and perform subsequent clinical infusion, which is not only convenient for daily operation, but also the thawed umbilical cord blood hematopoietic stem cells can be placed at 4°C for at least 72 hours, which can meet the needs of long-distance transportation.

[0010] The objective of the present invention is achieved through the following technical solutions:

[0011] A device for cleaning umbilical cord blood hematopoietic stem cells after thawing, comprising an infusion bag for storing thawed umbilical cord blood hematopoietic stem cells and a transfer bag for storing waste liquid, wherein a sample adding port and an infusion socket are respectively arranged on the upper part of the infusion bag, a Y-shaped pipeline is connected through the sample adding port, the other two ends of the Y-shaped pipeline are respectively connected to a puncture head and a Luer interface, a first pipeline clamp, a third pipeline clamp and a fourth pipeline clamp are respectively arranged on three sections of the Y-shaped pipeline, the infusion bag and the transfer bag are connected through a catheter, and a second pipeline clamp is arranged on the catheter.

[0012] A method for thawing, cleaning and preserving umbilical cord blood hematopoietic stem cells based on the above device comprises the following steps:

[0013] Step 1, umbilical cord blood cryopreservation: Take out the umbilical cord blood cryopreservation bag from the liquid nitrogen vapor phase, put it into a 37°C water bath and gently knead it. When only a small amount of ice residue remains in the cryopreservation bag, take it out of the water bath, disinfect the outer surface and put it into a biosafety cabinet;

[0014] Step 2, add thawing diluent: close the second and fourth pipeline clamps, keep the first and third pipeline clamps open, insert the puncture head into the infusion port of the umbilical cord blood freezing bag, and introduce the umbilical cord blood in the freezing bag into the infusion bag. Close the first pipeline clamp, open the fourth pipeline clamp, use a syringe to draw a thawing diluent of the same volume as the umbilical cord blood, and slowly add it to the infusion bag through the Luer interface in the device, and mix while adding. Close the third pipeline clamp, open the first pipeline clamp, use a syringe to draw a thawing diluent of the same volume as the umbilical cord blood again, and add it to the umbilical cord blood freezing bag through the Luer interface to clean the residual umbilical cord blood in the freezing bag. Close the fourth pipeline clamp, open the third pipeline clamp, and introduce the liquid in the freezing bag into the infusion bag, while guiding and mixing. Close the first pipeline clamp, open the fourth pipeline clamp, use a syringe to draw 2 to 3 times the volume of the umbilical cord blood thawing diluent, add it to the infusion bag through the Luer interface, and mix the infusion bag while adding. Close the third pipeline clamp, use a heat sealer to heat seal the pipeline between the third pipeline clamp and the sample adding port, and remove the third pipeline clamp and the part above it;

[0015] Step 3, centrifugation: vertically place the infusion bag and the transfer bag together in the blood bag centrifuge, centrifuge, carefully place the centrifuged infusion bag in the slurry separator, open the second pipeline clamp, allow the supernatant in the infusion bag to slowly flow into the transfer bag, and retain 1 / 6 to 1 / 5 of the supernatant; close the second pipeline clamp, heat-seal the catheter between the infusion bag and the transfer bag, and remove the transfer bag;

[0016] Step 4, adding cell preservation solution: Use a syringe to draw out a volume of cell preservation solution equal to the volume of umbilical cord blood, add it to the infusion bag through the sample addition port, and mix thoroughly to complete the thawing of umbilical cord blood hematopoietic stem cells.

[0017] Furthermore, the thawing dilution solution in step 2 contains human albumin and levofloxacin 40, and the mass fractions of the two are 2.5% and 5%, respectively.

[0018] Furthermore, the specific conditions of the centrifugation in step 3 are: 300×G, 10° C., and centrifugation for 10 minutes.

[0019] Furthermore, the cell preservation solution in step 4 is a compound electrolyte injection solution containing 2.5% human albumin by mass.

[0020] Compared with the prior art, the present invention has the following beneficial effects:

[0021] 1. The cord blood hematopoietic stem cell cleaning device after thawing of the present invention is specially designed for cleaning of thawed cord blood and subsequent clinical infusion, and has a simple structure and is convenient for daily operation;

[0022] 2. The method for thawing, cleaning and preserving umbilical cord blood hematopoietic stem cells of the present invention uses human albumin and low-molecular-weight dextran in the thawing diluent, which synergistically play the role of stabilizing osmotic pressure and cell morphology, and can effectively maintain the integrity and activity of the cells;

[0023] 3. The method for thawing, cleaning and preserving umbilical cord blood hematopoietic stem cells of the present invention uses a centrifugal force of 300×G to ensure sufficient precipitation and recovery of umbilical cord blood cells, while effectively avoiding damage to cells by centrifugation;

[0024] 4. The method for thawing, cleaning and preserving umbilical cord blood hematopoietic stem cells of the present invention cleans the thawed umbilical cord blood, effectively removes most of the DMSO and free hemoglobin in the umbilical cord blood, significantly reduces cell fragments, and thus effectively reduces the occurrence of adverse reactions to transfusion;

[0025] 5. The method for thawing, cleaning and preserving umbilical cord blood hematopoietic stem cells described in the present invention adopts a compound electrolyte injection solution containing 2.5% human albumin as the preservation solution for thawed umbilical cord blood hematopoietic stem cells. Firstly, human albumin can maintain the colloidal osmotic pressure, and play a protective and nutritional role on the cells. Meanwhile, the electrolyte injection solution provides a suitable crystal osmotic pressure and pH environment for cell growth, and provides necessary electrolyte components for cell metabolism. On the other hand, the thawed umbilical cord blood hematopoietic stem cells using the preservation solution can be placed at 4°C for at least 72 hours, and still maintain good activity and proliferation ability, which can basically meet the needs of long-distance transportation. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] Figure 1 This is a schematic diagram of the structure of the device for thawing umbilical cord blood hematopoietic stem cells according to Example 1 of the present invention;

[0027] Figure 2 Schematic diagram of changes in nucleated cell activity (n=3);

[0028] Figure 3 Schematic diagram of the changes in CD34+ cell activity (n=3);

[0029] Figure 4 Schematic diagram of the changes in the recovery rate of live CD34+ cells (n=3). DETAILED DESCRIPTION

[0030] Example 1

[0031] like Figure 1 As shown, this embodiment provides a post-thawing cleaning device for umbilical cord blood hematopoietic stem cells, including an infusion bag 1 for storing thawed umbilical cord blood hematopoietic stem cells and a transfer bag 2 for storing waste liquid. A sample addition port 101 and an infusion socket 102 are respectively arranged on the upper portion of the infusion bag 1, and a Y-shaped pipeline 3 is connected through the sample addition port. The other two ends of the Y-shaped pipeline are respectively connected to a puncture head 301 and a Luer interface 302. A first pipeline clamp 303, a third pipeline clamp 304 and a fourth pipeline clamp 305 are respectively arranged on the three sections of the Y-shaped pipeline. The infusion bag and the transfer bag are connected by a catheter 4, and a second pipeline clamp 401 is arranged on the catheter.

[0032] The method for thawing, cleaning and preserving umbilical cord blood hematopoietic stem cells using the above device comprises the following steps:

[0033] Step 1, thawing and resuscitation of umbilical cord blood: Take out the umbilical cord blood freezing bag from the liquid nitrogen vapor phase, put it into a 37°C water bath and gently knead it. When only a small amount of ice residue remains in the freezing bag, take it out of the water bath, disinfect the outer surface and put it into the biosafety cabinet.

[0034] Step 2, adding thawing diluent (performed in a biosafety cabinet): close the second pipeline clamp 401 and the fourth pipeline clamp 305, keep the first pipeline clamp 303 and the third pipeline clamp 304 open, insert the puncture head 301 into the infusion port of the umbilical cord blood freezing bag, and introduce the umbilical cord blood in the freezing bag into the infusion bag 1. Close the first pipeline clamp 303, open the fourth pipeline clamp 305, use a syringe to draw a volume of thawing diluent equal to the volume of the umbilical cord blood, and slowly add it to the infusion bag 1 through the Luer interface 302 in the device, and mix while adding. Close the third pipeline clamp 304, open the first pipeline clamp 303, use a syringe to draw a volume of thawing diluent equal to the volume of the umbilical cord blood again, and add it to the umbilical cord blood freezing bag through the Luer interface 302 to clean the residual umbilical cord blood in the freezing bag. Close the fourth pipeline clamp 305, open the third pipeline clamp 304, and introduce the liquid in the freezing bag into the infusion bag 1, and mix while introducing. Close the first pipeline clamp 303, open the fourth pipeline clamp 305, use a syringe to extract 3 times the volume of umbilical cord blood thawing diluent, add it to the infusion bag 1 through the Luer interface 302, and mix the infusion bag while adding. Close the third pipeline clamp 304, use a heat sealer to heat seal the pipeline part between the third pipeline clamp 304 and the sample addition port 101, and remove the third pipeline clamp 304 and the part above it.

[0035] The thawing diluent comprises 2.5% human albumin and 5% dextran 40, and the solution used is a commercially available human albumin solution (containing 20% ​​human albumin) and dextran 40 sodium chloride injection (containing 6% dextran 40).

[0036] Step 3, centrifugation: vertically place the infusion bag 1 and the transfer bag 2 together in a large-capacity blood bag centrifuge, centrifuge at 300×G, 10°C for 10 minutes. Carefully place the centrifuged infusion bag 1 in the slurry separation clamp, open the second pipeline clamp 401, and allow the supernatant in the infusion bag 1 to slowly flow into the transfer bag 2, retaining about 1 / 6 of the supernatant. Close the second pipeline clamp 401, heat-seal the catheter 4 between the infusion bag 1 and the transfer bag 2, and remove the transfer bag 2.

[0037] Step 4, adding cell preservation solution: use a syringe to extract a cell preservation solution of the same volume as the umbilical cord blood, add it into the infusion bag 1 through the sample addition port 101, and fully mix the infusion bag.

[0038] The cell preservation solution is composed of a compound electrolyte injection solution containing 2.5% human albumin (an aqueous solution for injection containing sodium chloride, sodium gluconate, sodium acetate, potassium chloride and magnesium chloride).

[0039] Step 5, storage and infusion: After cleaning and adding preservation solution, the umbilical cord blood can be placed in a 4°C environment for 72 hours. During infusion, connect the infusion set through the infusion port of the infusion bag and perform conventional intravenous infusion operations.

[0040] Use solutions that have obtained national drug approval numbers to prepare thawing diluents and cell preservation solutions to ensure the compliance and safety of subsequent clinical applications of umbilical cord blood products.

[0041] Experimental Example 1

[0042] After thawing and washing the frozen umbilical cord blood according to the method described in Example 1, the infusion bag was placed in a 4°C refrigerator, and sampling and testing were performed at 0 hours, 4 hours, 24 hours, 48 ​​hours, and 72 hours, respectively. The test items included cell counting, cell activity detection, and CD34+ cell detection.

[0043] The CD34 antigen is a specific antigen expressed on the surface of hematopoietic stem cells. CD34+ cells are generally considered to be hematopoietic stem cells, and the number of live CD34+ cells represents the number of hematopoietic stem / progenitor cells with proliferative activity.

[0044] Test results are shown in Figure 2-4 The calculation of the recovery rate is based on the test results at 0 hours. It can be seen that there is no significant difference in the activity of nucleated cells, CD34+ cell activity and the recovery rate of live CD34+ cells after 72 hours and 4 hours. Therefore, the technical solution of this embodiment can make the thawed umbilical cord blood hematopoietic stem cells maintain good proliferation ability and activity after at least 72 hours.

[0045] Under current transportation conditions, 72 hours is enough to transport cord blood specimens to any hematopoietic stem cell transplant hospital in China. Therefore, after the clinical hospital determines the time of use, the cord blood bank can thaw and resuscitate the cord blood in its own laboratory in advance, and finally transport it to the hospital for infusion in the form of an infusion bag using a 4°C low-temperature transport box. During the thawing process, if abnormal conditions such as damage to the frozen bag occur, it will be more convenient to handle in the cord blood bank laboratory, and the spare cord blood specimens can be thawed immediately, thereby effectively avoiding the potential risks of thawing in the clinical hospital.

[0046] In addition, the umbilical cord blood treated by the thawing method described in this embodiment can effectively remove the cryoprotectant, cell debris and free hemoglobin in the umbilical cord blood, with an average red blood cell clearance rate of 78.41% and an average free hemoglobin clearance rate of 83.39%.

[0047] At the same time, the thawing diluent and cell preservation solution used in this embodiment are both commercially available solutions that can be routinely intravenously infused, so while ensuring safety, some common adverse reactions of existing cord blood infusions can be reduced or avoided.

Claims

1. A method for thawing, cleaning and preserving umbilical cord blood hematopoietic stem cells, characterized in that: The method is based on a post-thaw cleaning device for umbilical cord blood hematopoietic stem cells, the device comprising an infusion bag (1) for storing thawed umbilical cord blood hematopoietic stem cells and a transfer bag (2) for storing waste liquid, the infusion bag (1) being provided with a sample addition port (101) and an infusion socket (102) at the upper portion thereof, connected to a Y-shaped pipeline (3) via the sample addition port, the other two ends of the Y-shaped pipeline being connected to a puncture head (301) and a Luer interface (302) respectively, the three sections of the Y-shaped pipeline being provided with a first pipeline clamp (303), a third pipeline clamp (304) and a fourth pipeline clamp (305) respectively, the infusion bag and the transfer bag being connected via a catheter (4), the catheter being provided with a second pipeline clamp (401); The method comprises the following steps: Step 1, umbilical cord blood cryopreservation: Take out the umbilical cord blood cryopreservation bag from the liquid nitrogen vapor phase, put it into a 37°C water bath and gently knead it. When only a small amount of ice residue remains in the cryopreservation bag, take it out of the water bath, disinfect the outer surface and put it into a biosafety cabinet; Step 2, adding thawing diluent: close the second pipeline clamp (401) and the fourth pipeline clamp (305), keep the first pipeline clamp (303) and the third pipeline clamp (304) open, insert the puncture head (301) into the infusion port of the umbilical cord blood freezing bag, so that the umbilical cord blood in the freezing bag is introduced into the infusion bag (1); close the first pipeline clamp (303), open the fourth pipeline clamp (305), use a syringe to draw a thawing diluent of the same volume as the umbilical cord blood, and slowly add it to the infusion bag (1) through the Luer interface (302) in the device. and mixing while adding; closing the third pipeline clamp (304), opening the first pipeline clamp (303), using a syringe to draw out a thawing diluent of the same volume as the umbilical cord blood again, adding it to the umbilical cord blood freezing bag through the Luer interface (302), and cleaning the residual umbilical cord blood in the freezing bag; closing the fourth pipeline clamp (305), opening the third pipeline clamp (304), and introducing the liquid in the freezing bag into the infusion bag (1), and mixing while introducing; closing the first pipeline clamp (303), opening the fourth pipeline clamp (305), using a syringe to draw out a thawing diluent of 2 to 3 times the volume of the umbilical cord blood, and adding it to the infusion bag (1) through the Luer interface (302), and mixing while adding it; closing the third pipeline clamp (304), using a heat sealer to heat seal the pipeline portion between the third pipeline clamp (304) and the sample addition port (101), and removing the third pipeline clamp (304) and the portion above it; The thawing diluent contains human albumin and dextran 40, the mass fractions of which are 2.5% and 5% respectively; Step 3, centrifugation: vertically place the infusion bag (1) and the transfer bag (2) together in a blood bag centrifuge for centrifugation, carefully place the centrifuged infusion bag (1) in a slurry separator, open the second pipeline clamp (401), allow the supernatant in the infusion bag (1) to slowly flow into the transfer bag (2), and retain 1 / 6 to 1 / 5 of the supernatant; close the second pipeline clamp (401), heat-seal the catheter (4) between the infusion bag (1) and the transfer bag (2), and remove the transfer bag (2); The specific conditions of the centrifugation treatment are: 300×G, 10°C, centrifugation for 10 minutes; Step 4, adding cell preservation solution: using a syringe to extract a volume of cell preservation solution equal to the volume of the umbilical cord blood, adding it to the infusion bag (1) through the sample addition port (101), and mixing thoroughly, thereby completing the thawing of the umbilical cord blood hematopoietic stem cells; The cell preservation solution is a compound electrolyte injection solution containing 2.5% by mass of human albumin.